Close Menu
July 15, 2019
Sponsored by

Proteomics for Precision Medicine: New Workflows to Support Translational Research


Senior Director,
Thermo Fisher Precision Science Center

Head of Applications,

This webinar addresses new translational workflows to support proteomic profiling for biomarker discovery through precision medicine.

Recent advances in mass spectrometry have expanded the opportunities for translational proteomics, which complements other omics disciplines such as genomics, transcriptomics, and metabolomics/lipidomics. However, a key challenge is bridging the gap between early-stage discovery and next-stage, routine quantitative application of biomarker assays in the clinical research setting.

To accelerate the discovery of clinically actionable biomarkers, workflow solutions need to address scalability, reproducibility, and robustness. They also need to support the analysis of larger patient cohorts.

Our first speaker, Emily Chen, senior director of the Thermo Fisher Precision Science Center, discusses the need to achieve precision proteomics as a first step toward achieving precision medicine. She presents precision medicine workflows that focus on biofluids and FFPE tissues and applications using these workflows.

Our second speaker, Nicolai Bache, head of applications at Evosep, discusses a new low-flow separation system for proteomics-based translational research.

More information on other webinars in this series can be found here.

Sponsored by

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.